Giant Biogene Holding Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Oct '24 Oct 9, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Market Capitalization	52,782	34,746	32,794	-	-	-
Market Cap Growth	36.24%	5.95%	-	-	-	-
Enterprise Value	46,273	31,750	31,531	-	-	-
Last Close Price	52.30	34.88	32.92	-	-	-
PE Ratio	27.07	21.39	29.68	-	-	-
PS Ratio	10.62	8.95	12.27	-	-	-
PB Ratio	8.23	7.22	10.22	-	-	-
P/FCF Ratio	29.37	22.19	37.24	-	-	-
P/OCF Ratio	22.94	19.14	31.14	-	-	-
EV/Sales Ratio	9.66	8.18	11.80	-	-	-
EV/EBITDA Ratio	21.31	17.54	24.07	-	-	-
EV/EBIT Ratio	21.71	17.88	24.61	-	-	-
EV/FCF Ratio	25.75	20.28	35.80	-	-	-
Debt / Equity Ratio	0.00	0.00	0.00	-	-	-
Debt / EBITDA Ratio	0.00	0.00	0.00	-	-	-
Debt / FCF Ratio	0.00	0.00	0.00	-	-	-
Asset Turnover	0.76	0.87	0.43	0.29	0.54	-
Inventory Turnover	2.96	3.00	2.70	2.57	3.18	-
Quick Ratio	3.57	7.36	8.16	1.07	1.02	1.54
Current Ratio	3.81	7.79	9.03	1.09	1.05	2.33
Return on Equity (ROE)	37.14%	40.18%	51.98%	112.30%	102.70%	-
Return on Assets (ROA)	21.27%	24.84%	12.86%	10.81%	22.62%	-
Return on Capital (ROIC)	26.11%	27.93%	36.73%	77.18%	62.50%	-
Earnings Yield	4.11%	4.60%	3.45%	-	-	-
FCF Yield	3.88%	4.51%	2.69%	-	-	-
Dividend Yield	0.92%	1.39%	-	-	-	-
Payout Ratio	0.00%	-	36.67%	307.92%	-	-
Buyback Yield / Dilution	1.01%	3.77%	-2.03%	-0.09%	-	-
Total Shareholder Return	1.92%	5.16%	-2.03%	-0.09%	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.